Elanco Animal Health Incorporated
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Elanco Animal Health Incorporated's yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Locked Ratio: For every $100 of sales, $49 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $49 tied up three years earlier. More money tied up than 92% of Healthcare companies in United States.
- Tangible Assets Ratio: Of every $100 the company owns, $39 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than 89% of Healthcare companies in United States.
- Cash Cushion Ratio: Debt, after subtracting cash, equals 31% of its market value (net debt). Lower than 89% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
2.4×Over the last 3 years its own operating cash covered its investment spending (capex) 2.4 times.
Higher than 76% of Healthcare companies in United States.
Cash Locked Ratio
$49For every $100 of sales, $49 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $49 tied up three years earlier.
More money tied up than 92% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 1/3Sales grew in 3 of the last 3 years; profit grew in 1 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
−$51Sales grew 7% in 3 years, but profit fell: $51 less profit per $100 of extra sales.
Lower than 82% of Healthcare companies in United States.
Asset Productivity Ratio
+7% / -14%In 3 years sales changed by +7% while total assets changed by -14%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
7.6×Debt due within a year is covered 7.6 times by its yearly operating cash.
Higher than 83% of Healthcare companies in United States.
Cash Cushion Ratio
−31%Debt, after subtracting cash, equals 31% of its market value (net debt).
Lower than 89% of Healthcare companies in United States.
Tangible Assets Ratio
39%Of every $100 the company owns, $39 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 89% of Healthcare companies in United States.
Tangible Net Worth Ratio
NegativeGoodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.
Less tangible than 81% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Elanco Animal Health Incorporated made a loss over the last year. Elanco Animal Health Incorporated owes $0.51 for every $1 it owns. Elanco Animal Health Incorporated made a loss in the year to Dec 2025, after a profit the year before.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossElanco Animal Health Incorporated made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
1.72The share price is 1.72 times Elanco Animal Health Incorporated's book value per share, lower than 63% of Healthcare companies in United States.
Market cap
$11.3 BThe total market value of all of Elanco Animal Health Incorporated's shares at today's price (share price × number of shares), larger than 91% of Healthcare companies in United States. PosiCap size class: Tito Cap.
Net worth (book value)
$6.6 BWhat Elanco Animal Health Incorporated would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$13.19Net worth divided by the number of shares. The share price of $22.69 is 1.7 times this, which is the P/B above.
Return on equity (ROE)
-3.0%Elanco Animal Health Incorporated lost 3.0% of its shareholders' money over the last year, higher than 74% of Healthcare companies in United States.
Owes vs Owns
0.51×Elanco Animal Health Incorporated owes $0.51 for every $1 it owns (moderate), higher than 57% of Healthcare companies in United States.
Dividend yield
NoneElanco Animal Health Incorporated does not currently pay a dividend.
Revenue growth
+6%Revenue rose 6% in the year to Dec 2025, and grew 2% a year on average over 3 years.
Profit growth
LossElanco Animal Health Incorporated made a loss in the year to Dec 2025, after a profit the year before.
Profit margin
-4.9%Elanco Animal Health Incorporated lost $5 for every $100 of revenue.
Interest cover
1.1×Elanco Animal Health Incorporated's operating profit covered its interest costs 1.1 times in the year to Dec 2025.
Cash vs debt
Net debtElanco Animal Health Incorporated had $3.5 B more debt than cash (net debt) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Elanco Animal Health Incorporated: $11.3 B ÷ $6.6 B (30 Jun 2026) = 1.7.
What is Elanco Animal Health Incorporated's return on equity?
Elanco Animal Health Incorporated lost 3.0% of its shareholders' money over the last year, higher than 74% of Healthcare companies in United States.
How much does Elanco Animal Health Incorporated owe compared with what it owns?
Elanco Animal Health Incorporated owes $0.51 for every $1 it owns (moderate), higher than 57% of Healthcare companies in United States.
Does Elanco Animal Health Incorporated pay a dividend?
No. Elanco Animal Health Incorporated does not currently pay a dividend.
Is Elanco Animal Health Incorporated's revenue growing?
Revenue rose 6% in the year to Dec 2025, and grew 2% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.